There are 2789 resources available
PD-1 checkpoint inhibitors in sarcoma: Evidence and future indications
Presenter: Sandra D'Angelo
Session: Exploring avenues for immunotherapy in sarcoma
Resources:
Slides
Webcast
CAR-T cells and other adaptive immune therapies in sarcoma
Presenter: Antonio Pérez-Martìnez
Session: Exploring avenues for immunotherapy in sarcoma
Resources:
Slides
Webcast
Can we take advantage of immunogenic death in soft tissue sarcomas?
Presenter: Olivier Mir
Session: Exploring avenues for immunotherapy in sarcoma
Resources:
Slides
Webcast
Introduction
Presenter: Martijn Lolkema
Session: Impact of lineage plasticity and heterogeneity on cancer therapies
Resources:
Webcast
Role of lineage plasticity in response and resistance to therapies
Presenter: Himisha Beltran
Session: Impact of lineage plasticity and heterogeneity on cancer therapies
Resources:
Slides
Webcast
Recapitulating human cancer through organoid models: Therapeutic implications of cellular heterogeneity
Presenter: Jeanine Roodhart
Session: Impact of lineage plasticity and heterogeneity on cancer therapies
Resources:
Slides
Webcast
How representative mouse models can provide insights to therapeutic vulnerabilities
Presenter: Katerina Politi
Session: Impact of lineage plasticity and heterogeneity on cancer therapies
Resources:
Slides
Webcast
Using repeated diagnostic leukapheresis to dissect resistance to treatment
Presenter: Martijn Lolkema
Session: Impact of lineage plasticity and heterogeneity on cancer therapies
Resources:
Slides
Webcast
The role of targeted therapy in the neo adjuvant setting
Presenter: Jamie Chaft
Session: Neoadjuvant immunotherapy of NSCLC
Resources:
Slides
Webcast
Introduction
Presenter: Laurence Albiges
Session: Personalised therapy in bladder and renal cancer
Resources:
Webcast